1
|
Yang L, Ma Q, Yu YY, Wang C, Meng WJ,
Adell G, Albertsson M, Arbman G, Jarlsfelt I, Peng ZH, et al:
Efficacy of surgery and adjuvant therapy in older patients with
colorectal cancer: A STROBE-compliant article. Medicine
(Baltimore). 93:e2662014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jacobs L, van der Vlies E, Ten Bokkel
Huinink D, Bloemendal H, Intven M, Smits AB, Weusten BLAM, Siersema
PD, van Lelyveld N and Los M: Tolerability, safety and outcome of
neoadjuvant chemoradiotherapy with capecitabine in Patients Aged
≥70 Years with locally advanced rectal cancer. Clin Colorectal
Cancer. 17:179–186. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Freischlag K, Sun Z, Adam MA, Kim J, Palta
M, Czito BG, Migaly J and Mantyh CR: Association between incomplete
neoadjuvant radiotherapy and survival for patients with locally
advanced rectal cancer. JAMA Surg. 152:558–564. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
National Comprehensive Cancer Network:
NCCN Guidelines, version 2. Rectal cancer. Fort Washington; PA:
National Comprehensive Cancer Network, . 2016
|
5
|
Wong RK, Tandan V, De Silva S and
Figueredo A: Pre-operative radiotherapy and curative surgery for
the management of localized rectal carcinoma. Cochrane Database
Syst Rev. CD0021022007.PubMed/NCBI
|
6
|
Brierley JD, Gospodarowicz MK and
Wittekind C: UICC international union against cancer. TMN
classification of malignant tumours. 8th. Wiley-Blackwell;
Chichester, UK: 2017
|
7
|
National cancer institute, . Common
terminology criteria for adverse events (CTCEA) version 4.0.
http://www.eortic.be/services/doc/ctc/CTCAE
4.032010-06-14QuickReference5x7.pdfUpdated 20102009.
|
8
|
Japanese Society for Cancer of the Colon
and Rectum, . General rules for clinical and pathological studies
on cancer of the colon, rectum and anus. 7th. Tokyo: Kanehara;
2009
|
9
|
Matsusaka S, Ishihara S, Kondo K, Horie H,
Uehara K, Oguchi M, Murofushi K, Ueno M, Mizunuma N, Shimbo T, et
al: A multicenter phase II study of preoperative chemoradiotherapy
with S-1 plus oxaliplatin for locally advanced rectal cancer
(SHOGUN trial). Radiother Oncol. 116:209–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
et al: Preoperative versus postoperative chemoradiotherapy for
rectal cancer. N Engl J Med. 351:1731–1740. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cai X, Wu H, Peng J, Zhu J, Cai S, Cai G
and Zhang Z: Tolerability and outcomes of radiotherapy or
chemoradiotherapy for rectal cancer in elderly patients aged 70
years and older. Radiat Oncol. 8:862013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Guimas V, Boustani J, Schipman B, Lescut
N, Puyraveau M, Bosset JF and Servagi-Vernat S: Preoperative
chemoradiotherapy for rectal cancer in patients aged 75 years and
older: Acute toxicity, compliance with treatment, and early
results. Drugs Aging. 33:419–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Margalit DN, Mamon HJ, Ancukiewicz M,
Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG and Hong
TS: Tolerability of combined modality therapy for rectal cancer in
elderly patients aged 75 years and older. Int J Radiat Oncol Biol
Phys. 81:e735–e741. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tougeron D, Roullet B, Paillot B, Hamidou
H, Tourani JM, Bensadoun RJ, Michel P and Silvain C: Safety and
outcome of chemoradiotherapy in elderly patients with rectal
cancer: Results from two French tertiary centres. Dig Liver Dis.
44:350–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ausili Cèfaro G, Genovesi D, Vinciguerra
A, Augurio A, Di Tmmaso M, Marchese R, Borzillo V, Tsciotti L,
Taraborrelli M, Innocenti P, et al: Effects of preoperative
radiochemotherapy with capecitabine for resectable locally advanced
rectal cancer in elderly patients. Tumori. 98:622–629. 2012.
View Article : Google Scholar : PubMed/NCBI
|
16
|
De Felice F, Musio D, Izzo L, Pugliese F,
Izzo P, Bolognese A and Tombolini V: Preoperative chemoradiotherapy
in elderly patients with locally advanced rectal cancer. Biomed Res
Int. 2013:6107862013. View Article : Google Scholar : PubMed/NCBI
|
17
|
De Felice F, Llange K, Rubini F,
Bulzonetti N, Caiazzo R, Musio D and Tombolini V: Intensified
neoadjuvant chemoradiotherapy for locally advanced rectal cancer in
elderly patients: Toxicity, disease control, and survival outcomes.
Clin Colorectal Cancer. 17:e77–e81. 2018. View Article : Google Scholar : PubMed/NCBI
|
18
|
Inoue Y, Kawamoto A, Okugawa Y, Hiro J,
Saigusa S, Toiyam Y, Araki T, Tanaka K, Mohri Y and Kusunoki M:
Efficacy and safety of laparoscopic surgery in elderly patients
with colorectal cancer. Mol Clin Oncol. 3:897–901. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Baré M, Montón C, Mora L, Redondo M, Pont
M, Escobar A, Sarasqueta C, Fernández de Larrea N, Briones E and
Quntana JM: COPD is a clear risk factor for increased use of
resources and adverse outcomes in patients undergoing intervention
for colorectal cancer: A nationwide study in Spain. Int J Chron
Obstruct Pulmon Dis. 12:1233–1241. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nishikawa T, Ishihara S, Hata K, Murono K,
Yasuda K, Otani K, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, et al:
Short-term outcomes of open vs. laparoscopic surgery in elderly
patients with colorectal cancer. Surg Endsc. 30:5550–5557. 2016.
View Article : Google Scholar
|
21
|
Hinoi T, Kawaguchi Y, Hattori M, Okajima
M, Ohdan H, Yamamoto S, Hasegawa H, Horie H, Murata K, Yamaguchi S,
et al: Laparoscopic versus open surgery for colorectal cancer in
elderly patients: A multicenter matched case-control study. Ann
Surg Oncol. 22:2040–2050. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Robinson CN, Balentine CJ, Marshall CL,
Wilks JA, Anaya D, Artinyan A, Berger DH and Albo D: Minimally
invasive surgery improves short-term outcomes in elderly colorectal
cancer patients. J Surg Res. 166:182–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shigeta K, Baba H, Yamafuji K, Asami A,
Takeshima K, Nagasaki K, Okamoto N, Murata T, Arai S, Kubochi K and
Kitagawa Y: Effects of laparoscopic surgery on the patterns of
death in elderly colorectal cancer patients: Competing risk
analysis compared with open surgery. Surg Today. 46:422–429. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Gillou PJ, Quirke P, Thorpe H, Walker J,
Jane DG, Smith AM, Heath RM and Brown JM; MRC CLASICC trial group,
: Short-term endpoints of conventional versus laparoscopic-assisted
surgery in patients with colorectal cancer (MRC CLASICC trial):
Multicentre, randomized controlled traial. Lancet. 365:1718–1726.
2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lujan J, Valero G, Hernandez Q, Sanchez A,
Frutos MD and Parrilla P: Randomized clinical trial comparing
loparoscopic and open surgery in patients with rectal cancer. Br J
Surg. 96:982–989. 2009. View
Article : Google Scholar : PubMed/NCBI
|
26
|
van der Pas MH, Haglind E, Cuesta MA,
Fürst A, Lacy AM, Hop WC and Bonjer HJ; COlorectal cancer
Laparoscopic or Open Resection II (COLOR II) Study Group, :
Laparoscopic versus open surgery for rectal cancer (COLOR II):
Short-term outcomes of a randomised, phase 3 trial. Lancet Oncol.
14:210–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fleshman J, Branda M, Sargent DJ, Boller
AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, et
al: Effect of laparoscopic-assisted resection vs. open resection of
Stage II or III rectal cancer on pathologic outcomes. The ACOSOG
Z6051 randomized clinical trial. JAMA. 314:1346–1355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Stevenson AR, Solomon MJ, Lumley JW,
Hewett P, Clouston AD, Gebski VJ, Davies L, Wilsn K, Hague W and
Simes J; ALaCaRT Investigators, : Effect of laparoscopic-assisted
resection vs. open resection on pathological outcomes in rectal
cancer. The ALaCaRT randomized clinical trial. JAMA. 314:1356–1363.
2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kim MJ, Kim YS, Park SC, Sohn DK, Kim DY,
Chang HJ and Oh JH: Risk factors for permanent stoma after rectal
cancer surgery with temporary ileostomy. Surgery. 159:721–727.
2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Hassan I, Larson DW, Wolff BG, Cima RR,
Chua HK, Hahnloser D, O'Byrne MM, Larson DR and Pemberton JH:
Impact of pelvic radiotherapy on morbidity and durability of
sphincter preservation after coloanal anastomosis for rectal
cancers. Dis Colon Rectum. 51:32–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lindgren R, Hallböök O, Rutegård J,
Sjödahl R and Matthiessen P: What is the risk for a permanent stoma
after low anterior resection of the rectum for cancer? A six-year
follow-up of a multicenter trial. Dis Colon Rectum. 54:41–47. 2011.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Abe S, Kawai K, Nozawa H, Hata K,
Kiyomatsu T, Tanaka T, Nishikawa T, Otani K, Sasaki K, Kaneko M, et
al: Use of a nomogram to predict the closure rate of diverting
ileostomy after low anterior resection: A retrospective cohort
study. Int J Surg. 47:83–88. 2017. View Article : Google Scholar : PubMed/NCBI
|